Micro
Developing
Active
Alphatec Holdings, Inc. (ATEC) stock analysis
Gaining traction — growing article coverage and momentum.
Score
0.4
Velocity
▲ 1.0
Articles
6
Sources
2
Sentiment Timeline
Sector Performance
Stock Performance
Event Timeline
Related Articles
Here is Why Alphatec (ATEC) is One of the Best Cheap Stocks Under $10 to …
Yahoo Finance
·
Jun 01, 2026
AXT Inc. (AXTI) Climbs to All-Time High Ahead of Investor Meeting
Yahoo Finance
·
May 24, 2026
Alphatec Holdings (ATEC) Slid on Investors’ Reaction Towards Company and Sector Factors
Yahoo Finance
·
May 14, 2026
This Fund Disclosed Selling $18 Million in Alphatec Last Quarter. The Stock Just Tanked 20% …
Nasdaq
·
May 05, 2026
Is Alphatec Holdings, Inc. (ATEC) A Good Stock To Buy Now?
Yahoo Finance
·
Mar 21, 2026
🤖
AI Overview
What happened: Alphatec Holdings, Inc. (ATEC) stock experienced a significant sell-off in late March 2026. Western Standard sold 1,232,881 shares, valued at approximately $18 million, leading to a 20% drop in ATEC's stock price post-earnings. Concurrently, ATEC's CFO sold 79,789 shares, worth around $986,000, reducing his direct ownership to 600,721 shares.
Market impact: The substantial selling by Western Standard and ATEC's CFO drove a significant price decline for ATEC shares. This sell-off may indicate a loss of confidence in the company's prospects, potentially impacting other medical device stocks in the sector. The forward P/E ratio of 63.69 suggests high valuation, which could make ATEC vulnerable to further downward pressure.
What to watch next: Upcoming catalysts include ATEC's Q1 2026 earnings release, scheduled for May 10, 2026, which will provide insights into the company's financial health and growth prospects. Additionally, any further significant changes in institutional holdings or insider trading activity should be monitored, as they could signal shifts in investor sentiment and drive additional market movements.
Market impact: The substantial selling by Western Standard and ATEC's CFO drove a significant price decline for ATEC shares. This sell-off may indicate a loss of confidence in the company's prospects, potentially impacting other medical device stocks in the sector. The forward P/E ratio of 63.69 suggests high valuation, which could make ATEC vulnerable to further downward pressure.
What to watch next: Upcoming catalysts include ATEC's Q1 2026 earnings release, scheduled for May 10, 2026, which will provide insights into the company's financial health and growth prospects. Additionally, any further significant changes in institutional holdings or insider trading activity should be monitored, as they could signal shifts in investor sentiment and drive additional market movements.
AI Overview as of May 05, 2026
Timeline
First SeenMar 21, 2026
Last UpdatedMar 21, 2026